Why the study?
Does the combined use of phenoxybenzamine and dopamine improve the ability to come off cardiopulmonary bypass in infants and children with low cardiac output syndrome?
Does the combined use of phenoxybenzamine and dopamine improve the ability to come off cardiopulmonary bypass in infants and children with low cardiac output syndrome?
The combination of phenoxybenzamine and dopamine may facilitate weaning from cardiopulmonary bypass in pediatric patients with low cardiac output syndrome by optimizing hemodynamics.
May aid weaning from bypass in select pediatric cases; hypothesis-generating and should not yet change practice.
The combined use of phenoxybenzamine and dopamine was applied in infants and children when it was difficult to come off cardiopulmonary bypass for low cardiac output. The rationale of this method is to prevent the alpha-adrenergic action of dopamine by phenoxybenzamine and to encourage the beta-adrenergic and direct specific action of dopamine. Dopamine was used in dosage of 10 to 30 micrograms/kg per min after the additional administration of a half of the initial dosage of phenoxybenzamine; this was infused by drip always in a dosage of 0.5 to 1.0 mg/kg during the first half of cardiopulmonary bypass. It was possible to come off cardiopulmonary bypass with a stable haemodynamic state (mean arterial pressure more than 60 mmHg and total peripheral vascular resistance less than 2000 bynes s cm-5) and a good urinary output.
No takes yet. Share an insight, caveat, or question.
Minamikawa et al. (1980) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: